PAREXEL International Corporation (PRXL)

26.76 +0.45  +1.71%  May 31, 4:37PM Go Pro
Watch this stock
View Full Chart PRXL Price Chart

Key Stats

Market Cap 1.592B
Revenue Growth 16.74%
Profit Margin 5.55%
Earnings Yield 2.69%
Dividend Yield 0.00%
Earnings Per Share TTM 0.72
PE Ratio 37.17
Price / Sales Ratio 1.045
52 Week High 28.74
52 Week Low 15.26
Beta 1.175
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

8:22 AM Listen to $PRXL 2012 investor meeting - live at 08:30 AM, ondemand after - http://stks.co/42qV by earningscast
6:28AM For Ellen Zane, no rest in retirement
May 30 PAREXEL (PRXL) Reaffirms Q4 Guidance, Offers FY13 Outlook Street Insider
May 30 PAREXEL International Sees Fy 2013 Revenue $1.625-2.655B vs $1.63B; GAAP EPS $1.3-1.4...
May 30 InPlay: PAREXEL reaffirms its guidance for the fourth quarter of fiscal year 2012 and...
May 30 PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day PR Newswire
May 30 Here's 1 Reason PAREXEL International Looks Weak Fool
May 29 PAREXEL International Corporation [PRXL] to Ring The NASDAQ Stock Market Opening Bell GlobeNewswire
May 29 PAREXEL Chairman And CEO To Ring The Bell At The NASDAQ Stock Market Opening PR Newswire
May 23 PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies...
May 10 $PRXL filed latest Quarterly Report http://stks.co/3luh by MarketBrief
May 01 Listen to $PRXL Q3 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3bIo by earningscast
May 01 $PRXL is 6.4% up since open on unusual high volume but still -6.2% down since close. by TradeBot
May 01 Today's biggest down-gaps: $PBY (-22,1%) $QNST (-14,8%) $IDTI (-12,2%) $VPHM (-12,0%) $PRXL (-11,8%) $DPZ (-10,6%) $ARW (-10,5%) by TradeBot

Profile

Exchange: NASDAQGS       Sector: Healthcare       Industry: Medical Laboratories & Research

PAREXEL International Corp. provides clinical research and development services. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics (Perceptive). The company offers contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. It also provides development and commercialization continuum services, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. The company was founded by Josef von Rickenbach in 1983 and is headquartered in Waltham, Massachusetts.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). PAREXEL International Corporation is up 6.32% over the last year vs S&P 500 Total Return up 0.88%, Icon down 16.14%, and Covance down 21.30%.

  • PRXL Total Returns
  • ^SPXTR Total Returns
  • ICLR Total Returns
  • CVD Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Cash Flow Statement View Statement

Get Quote for

Pro Strategies Featuring PRXL

Did PAREXEL International Corporation make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

PRXL Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
PRXL 26.76 +0.45 +1.71% 1.566B
PRXI 2.32 +0.13 +5.94% 103.85M
PRX 35.84 -1.17 -3.16% 1.353B
PRWTD 1.51 -0.04 -2.58%
PRWT 1.51 -0.04 -2.58% 15.15M
PRU 46.45 -0.20 -0.43% 21.92B
PLL 55.65 -0.76 -1.35% 6.510B
PLG 1.19 -0.01 -0.83% 213.11M
PLFE 8.84 +0.04 +0.45% 260.30M
PLD 32.00 +0.21 +0.66% 14.62B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close